DiscGenics’ Post

We are proud to announce a research collaboration with the U.S. Department of Veterans Affairs for tissue-engineered discs with DiscGenics' proprietary Discogenic Cells. This project, led by Sarah Gullbrand at the University of Pennsylvania, has been awarded BRAVE Funding by the VA Technology Transfer Program to support a large animal study of Discogenic Cell-derived implants. In the words of Kevin Foley, M.D., DiscGenics' Chief Medical Officer and practicing neurosurgeon: "A biologic disc replacement in lieu of existing mechanical devices would continue to change the paradigm of spine care away from a device-centric model to one of disease modification through biologic and cell-based treatments." Learn more here: https://prn.to/46BlvNH